首页> 外文期刊>Cytotechnology >Long-term stable production of monocyte-colony inhibition factor (M-CIF) from CHO microcarrier perfusion cultures
【24h】

Long-term stable production of monocyte-colony inhibition factor (M-CIF) from CHO microcarrier perfusion cultures

机译:从CHO微载体灌注培养物中长期稳定生产单核细胞集落抑制因子(M-CIF)

获取原文
       

摘要

Monocyte-colony inhibition factor (M-CIF) was produced in microcarrier perfusion cultures from engineered Chinese hamster ovary (CHO) cells. Three and fifteen liter microcarrier perfusion bioreactors equipped with internal spin filters were operated for over two months. Approximately 60 L and 300 L of culture filtrate were harvested from the 3L and 15L microcarrier perfusion bioreactors respectively. During the perfusion operation, cell density reached 2–6 × 106 cells/ml. Importantly, stable expression of M-CIF from the CHO cells under non-selection condition was maintained at a level of 4–10 mg/L. Specific productivity was maintained at 1.8–3.4 mg/billion cells/day. The ability of the recombinant CHO cells to migrate from microcarrier to microcarrier under our proprietary HGS-CHO-3 medium greatly facilitated microcarrier culture scale-up and microcarrier replenishment. Future directions for microcarrier perfusion system scale-up and process development are highlighted.
机译:单核细胞集落抑制因子(M-CIF)是从中国仓鼠卵巢(CHO)细胞的微载体灌注培养物中产生的。配备内部旋转过滤器的3升和15升微载体灌注生物反应器运行了两个月以上。分别从3L和15L微载体灌注生物反应器中收获大约60 L和300 L培养物滤液。在灌注过程中,细胞密度达到2–6×106细胞/ ml。重要的是,在非选择条件下,CHO细胞中M-CIF的稳定表达保持在4-10 mg / L的水平。比生产率保持在1.8-3.4 mg /十亿个细胞/天。在我们专有的HGS-CHO-3培养基下,重组CHO细胞从微载体迁移到微载体的能力极大地促进了微载体培养的规模化和微载体的补充。着重指出了微载体灌注系统扩大规模和工艺开发的未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号